Cystic teratoma

Summary

Cystic teratoma (MONDO:0002379) is a disease. A subtype of teratoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	cystic teratoma
Mondo ID	MONDO:0002379
DOID	DOID:2660
ICD-11	882254343
NCIT	C9014
UMLS	C1368903
MedGen	234578
GARD	0023128
Is cancer (heuristic)	no

Also known as: cystic teratoma

Disease family

This is a subtype of teratoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › nongerminomatous germ cell tumor › teratoma › cystic teratoma

Related subtypes (12): central nervous system teratoma, gastric teratoma, malignant teratoma, fallopian tube teratoma, adult teratoma, mature teratoma, mediastinum teratoma, gonadal teratoma, teratoma with malignant transformation, nasopharyngeal teratoma, immature teratoma, sacrococcygeal teratoma

Subtypes (3): dermoid cyst, ovarian cystic teratoma, adult cystic teratoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.